By Dr Sara Mohamed

Book Chapters

Abdel Samie SM; Nasr M, 2020, 'Food to medicine transformation of stilbenoid vesicular and lipid-based nanocarriers: Technological advances', in Drug Delivery Aspects, Elsevier, pp. 227 - 245, http://dx.doi.org/10.1016/b978-0-12-821222-6.00011-7

Journal articles

Mohamed SMA; Schofield P; Evans K; Friedrich KH; Christ D; Bayat N; Lock RB, 2026, 'A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia', Leukemia, pp. 1 - 5, http://dx.doi.org/10.1038/s41375-026-02976-5

Watts B; Smith CM; Evans K; Gifford AJ; Mohamed SMA; Erickson SW; Earley EJ; Neuhauser S; Stearns TM; Philip VM; Chuang JH; Zweidler-McKay PA; Lakshmikanthan S; Jocoy EL; Bult CJ; Teicher BA; Smith MA; Lock RB, 2025, 'The CD123 antibody–drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia', Hemasphere, 9, pp. e70063, http://dx.doi.org/10.1002/hem3.70063

Truong P; Shen S; Joshi S; Islam MI; Zhong L; Raftery MJ; Afrasiabi A; Alinejad-Rokny H; Nguyen M; Zou X; Bhuyan GS; Sarowar CH; Ghodousi ES; Stonehouse O; Mohamed S; Toscan CE; Connerty P; Kakadia PM; Bohlander SK; Michie KA; Larsson J; Lock RB; Walkley CR; Thoms JAI; Jolly CJ; Pimanda JE, 2024, 'TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells', Nature Communications, 15, pp. 7360, http://dx.doi.org/10.1038/s41467-024-51646-6

Mohamed SMA; Schofield P; McCalmont H; Moles E; Friedrich KH; Kavallaris M; Christ D; Bayat N; Lock RB, 2024, 'An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia', International Journal of Biological Macromolecules, 254, http://dx.doi.org/10.1016/j.ijbiomac.2023.127596

Mohamed SMA; Wohlmann A; Schofield P; Sia KCS; McCalmont H; Savvides SN; Verstraete K; Kavallaris M; Christ D; Friedrich KH; Bayat N; Lock RB, 2021, 'A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia', International Journal of Biological Macromolecules, 190, pp. 214 - 223, http://dx.doi.org/10.1016/j.ijbiomac.2021.08.194

AbdelSamie SM; Kamel AO; Sammour OA; Ibrahim SM, 2016, 'Terbinafine hydrochloride nanovesicular gel: In vitro characterization, ex vivo permeation and clinical investigation', European Journal of Pharmaceutical Sciences, 88, pp. 91 - 100, http://dx.doi.org/10.1016/j.ejps.2016.04.004

Conference Abstracts

Mohamed SMA; Sia K; Friedrich K-H; Wohlmann A; Savvides S; Schofield P; Christ D; Kavallaris M; Lock RB; Bayat N, 2020, 'A Novel Engineered Single-Chain Antibody Fragment for Targeting Pediatric Philadelphia Chromosome-like Acute Lymphoblastic Leukemia', in Blood, American Society of Hematology, Vol. 136, pp. 36, http://dx.doi.org/10.1182/blood-2020-138421

Preprints

Truong P; Shen S; Joshi S; Islam I; Zhong L; Raftery MJ; Afrasiabi A; Alinejad-Rokny H; Nguyen M; Zou X; Bhuyan GS; Sarowar CH; Ghodousi ES; Stonehouse O; Mohamed S; Toscan CE; Connerty P; Kakadia PM; Bohlander SK; Michie KA; Larsson J; Lock RB; Walkley CR; Thoms JAI; Jolly CJ; Pimanda JE, Genome-Wide CRISPR-Cas9 Screening Identifies a Synergy between Hypomethylating Agents and SUMOylation Blockade in MDS/AML, http://dx.doi.org/10.1101/2024.04.17.589858

Back to profile page